Senior Columnist, The Street
Adam Feuerstein tweeted...
View Adam Feuerstein's timeline and complete journalist profile →
My second story on #ASCO12 data, focused on $PFE $GSK $JNJ (Zytiga). The latter impressive, bodes well for $MDVN http://t.co/hjlmWxAE— Adam Feuerstein (@) May 16, 2012
Sign up to discover more journalists who cover and more.Create An Account
Share This Profile